Solvay SA 2010 AR2
The report highlights Solvay's strategic transformation in 2010, marked by the sale of its pharmaceuticals business to Abbott for EUR 5.1 billion and the divestment of its stake in Inergy Automotive Systems. The company launched the Horizon project to reorganize its structure into more agile global and regional business units to focus on sustainable chemistry. Financially, Solvay achieved sales of EUR 7.1 billion, with continuing operations up 19% to EUR 6.8 billion, and a recurring operating result (REBIT) of EUR 633 million. In sustainability, the group reduced its greenhouse gas emissions and advanced its conversion from mercury to membrane electrolysis at key European sites.
Company: Solvay SA
Sector: Manufacturing
Country: Belgium
Year: 2010
Type: AR2
Pages: 206
Back to company
Solvay SA
Annual Report
The report highlights Solvay's strategic transformation in 2010, marked by the sale of its pharmaceuticals business to Abbott for EUR 5.1 billion and the divestment of its stake in Inergy Automotive Systems. The company launched the Horizon project to reorganize its structure into more agile global and regional business units to focus on sustainable chemistry. Financially, Solvay achieved sales of EUR 7.1 billion, with continuing operations up 19% to EUR 6.8 billion, and a recurring operating result (REBIT) of EUR 633 million. In sustainability, the group reduced its greenhouse gas emissions and advanced its conversion from mercury to membrane electrolysis at key European sites.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2010
Reporting Period
Jan 1, 2010 - Dec 31, 2010
Fiscal Year
2010
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees